Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia

Critical Care Medicine

Volumn 34, Issue 7, 2006, Pages 1947-1954

  Witzenrath, Martin ^a   Gutbier, Birgitt ^a   Hocke, Andreas C ^a   Schmeck, Bernd ^a   Hippenstiel, Stefan ^a   Berger, Katharina ^a   Mitchell, Timothy J ^b   De Los Toyos, Juan R ^c   Rosseau, Simone ^a   Suttorp, Norbert ^a   Schütte, Hartwig ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

Acute lung injury; Endothelial permeability; Isolated mouse lung; Pneumococcal pneumonia; Pneumolysin; Pulmonary hypertension

Indexed keywords

PNEUMOLYSIN; RECOMBINANT PROTEIN; VIRULENCE FACTOR;

ACUTE LUNG INJURY; ACUTE RESPIRATORY FAILURE; ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; CELL IMPEDANCE; CELL STRAIN; CELL STRAIN A549; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN UMBILICAL VEIN ENDOTHELIUM CELL; HYDRAULIC CONDUCTIVITY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMPEDANCE; IN VITRO STUDY; IN VIVO STUDY; ISOLATED LUNG; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; STRESS FIBER;

AEROSOLS; ANIMALS; BACTERIAL PROTEINS; CAPILLARY PERMEABILITY; CELL MEMBRANE PERMEABILITY; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; EPITHELIAL CELLS; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG DISEASES; MICE; MICROCIRCULATION; PNEUMONIA, PNEUMOCOCCAL; PULMONARY ALVEOLI; PULMONARY CIRCULATION; STREPTOLYSINS; VASCULAR RESISTANCE;

EID: 33745629065     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000220496.48295.A9     Document Type: Article

References (48)

1. Angus DC, Marrie TJ, Obrosky DS, et al: Severe community-acquired pneumonia: Use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med 2002; 166:717-723
2. Woodhead M: Community-acquired pneumonia in Europe: Causative pathogens and resistance patterns. Eur Respir J Suppl 2002; 36:20s-27s.
3. Marrie TJ: Pneumococcal pneumonia: Epidemiology and clinical features. Semin Respir Infect 1999; 14:227-236
4. File TM: Community-acquired pneumonia. Lancet 2003; 362:1991-2001
5. Cockeran R, Anderson R, Feldman C: The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection. Curr Opin Infect Dis 2002; 15:235-239
6. Hirst RA, Kadioglu A, O'Callaghan C, et al: The role of pneumolysin in pneumococcal pneumonia and meningitis. Clin Exp Immunol 2004; 138:195-201
7. Jedrzejas MJ: Pneumococcal virulence factors: Structure and function. Microbiol Mol Biol Rev 2001; 65:187-207
8. Mitchell TJ: Virulence factors and the pathogenesis of disease caused by Streptococcus pneumoniae. Res Microbiol 2000; 151:413-419
9. Paton JC: The contribution of pneumolysin to the pathogenicity of Streptococcus pneumoniae. Trends Microbiol 1996; 4:103-106
10. Rubins JB, Charboneau D, Paton JC, et al: Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J Clin Invest 1995; 95:142-150
11. Musher DM, Phan HM, Baughn RE: Protection against bacteremic pneumococcal infection by antibody to pneumolysin. J Infect Dis 2001; 183:827-830
12. Benton KA, Everson MP, Briles DE: A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice. Infect Immun 1995; 63:448-455
13. Rubins JB, Duane PG, Charboneau D, et al: Toxicity of pneumolysin to pulmonary endothelial cells in vitro. Infect Immun 1992; 60:1740-1746
14. Rubins JB, Duane PG, Clawson D, et al: Toxicity of pneumolysin to pulmonary alveolar epithelial cells. Infect Immun 1993; 61:1352-1358
15. Cockeran R, Durandt C, Feldman C, et al: Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J Infect Dis 2002; 186:562-565
16. Mitchell TJ, Andrew PW, Saunders FK, et al: Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol Microbiol 1991; 5:1883-1888
17. Cockeran R, Steel HC, Mitchell TJ, et al: Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils. Infect Immun 2001; 69:3494-3496
18. Cockeran R, Theron AJ, Steel HC, et al: Proinflammatory interactions of pneumolysin with human neutrophils. J Infect Dis 2001; 183:604-611
19. Walmrath D, Scharmann M, Konig R, et al: Staphylococcal alpha-toxin induced ventilation-perfusion mismatch in isolated blood-free perfused rabbit lungs. J Appl Physiol 1993; 74:1972-1980
20. Schutte H, Rosseau S, Czymek R, et al: Synergism between endotoxin priming and exotoxin challenge in provoking severe vascular leakage in rabbit lungs. Am J Respir Crit Care Med 1997; 156:819-824
21. Walmrath D, Ghofrani HA, Rosseau S, et al: Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo- and exotoxin. J Exp Med 1994; 180:1437-1443
22. Schmeck B, Zahlten J, Moog K, et al: Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor. J Biol Chem 2004; 279:53241-53247
23. Opitz B, Puschel A, Schmeck B, et al: Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem 2004; 279:36426-36432
24. Matute-Bello G, Frevert CW, Liles WC, et al: Fas/Fas ligand system mediates epithelial injury, but not pulmonary host defenses, in response to inhaled bacteria. Infect Immun 2001; 69:5768-5776
25. Kadioglu A, Gingles NA, Grattan K, et al: Host cellular immune response to pneumococcal lung infection in mice. Infect Immun 2000; 68:492-501
26. Seybold J, Thomas D, Witzenrath M, et al: Tumor necrosis factor-alpha-dependent expression of phosphodiesterase 2: Role in endothelial hyperpermeability. Blood 2005; 105:3569-3576
27. von Bethmann AN, Brasch F, Nusing R, et al: Hyperventilation induces release of cytokines from perfused mouse lung. Am J Respir Crit Care Med 1998; 157:263-272
28. Paton JC, Andrew PW, Boulnois GJ, et al: Molecular analysis of the pathogenicity of Streptococcus pneumoniae: The role of pneumococcal proteins. Annu Rev Microbiol 1993; 47:89-115
29. Folz RJ, Abushamaa AM, Suliman HB: Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J Clin Invest 1999; 103:1055-1066
30. Hippenstiel S, Witzenrath M, Schmeck B, et al: Adrenomedullin reduces endothelial hyperpermeability. Circ Res 2002; 91:618-625
31. Suttorp N, Weber U, Welsch T, et al: Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J Clin Invest 1993; 91:1421-1428
32. Giaever I, Keese CR: A morphological biosensor for mammalian cells. Nature 1993; 366:591-592
33. Garcia JG, Schaphorst KL, Shi S, et al: Mechanisms of ionomycin-induced endothelial cell barrier dysfunction. Am J Physiol 1997; 273:L172-L184
34. Tiruppathi C, Malik AB, Del Vecchio PJ, et al: Electrical method for detection of endothelial cell shape change in real time: Assessment of endothelial barrier function. Proc Natl Acad Sci U S A 1992; 89:7919-7923
35. Cima-Cabal MD, Vazquez F, de los Toros JR, et al: Rapid and reliable identification of Streptococcus pneumoniae isolates by pneumolysin-mediated agglutination. J Clin Microbiol 1999; 37:1964-1966
36. Ermert L, Hocke AC, Duncker HR, et al: Comparison of different detection methods in quantitative microdensitometry. Am J Pathol 2001; 158:407-417
37. Rubins JB, Charboneau D, Fasching C, et al: Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am J Respir Crit Care Med 1996; 153:1339-1346
38. Jounblat R, Kadioglu A, Mitchell TJ, et al: Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin. Infect Immun 2003; 71:1813-1819
39. Feldman C, Munro NC, Jeffery PK, et al: Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo. Am J Respir Cell Mol Biol 1991; 5:416-423
40. Rijneveld AW, van den Dobbelsteen GP, Florquin S, et al: Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. J Infect Dis 2002; 185:123-126
41. Maus UA, Srivastava M, Paton JC, et al: Pneumolysin-induced lung injury is independent of leukocyte trafficking into the alveolar space. J Immunol 2004; 173:1307-1312
42. Zysk G, Schneider-Wald BK, Hwang JH, et al: Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae. Infect Immun 2001; 69:845-852
43. Cundell DR, Gerard NP, Gerard C, et al: Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995; 377:435-438
44. Ermert L, Rousseau S, Schutte H, et al: Induction of severe vascular leakage by low doses of Escherichia coli hemolysin in perfused rabbit lungs. Lab Invest 1992; 66:362-369
45. Dejana E: Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J Clin Invest 1996; 98:1949-1953
46. Corada M, Mariotti M, Thurston G, et al: Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci U S A 1999; 96:9815-9820
47. Rabiet MJ, Plantier JL, Rival Y, et al: Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler Thromb Vasc Biol 1996; 16:488-496
48. Andriopoulou P, Navarro P, Zanetti A, et al: Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler Thromb Vasc Biol 1999; 19:2286-2297